From
Send to

Kyongbo Pharm's production facilities receive FDA approval

June 27, 2016 - 10:22 By 황유미
[DISCLOSURE] Kyongbo Pharmaceutical (214390) announced on June 27 that its GMP production facilities have been approved by USFDA. The pharmaceutical company had applied for FDA inspection to export its antibiotics raw material in February.